Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹8,421 Cr
Revenue (TTM)
₹2,550 Cr
Net Profit (TTM)
₹358 Cr
ROE
16.9 %
ROCE
17.7 %
P/E Ratio
23.5
P/B Ratio
4.4
Industry P/E
27.71
EV/EBITDA
12.4
Div. Yield
0.3 %
Debt to Equity
0.2
Book Value
₹441.5
EPS
₹84.4
Face value
10
Shares outstanding
43,141,338
CFO
₹2,562.41 Cr
EBITDA
₹3,102.76 Cr
Net Profit
₹1,521.47 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Epigral
| 2.1 | 3.1 | 9.2 | 51.1 | 16.9 | -- | -- |
|
BSE Commodities
| 6.8 | 5.4 | 11.5 | 5.5 | 14.2 | 30.1 | -- |
|
BSE Small Cap
| -6.2 | 7.2 | 13.1 | 7.2 | 25.8 | 37.8 | 16.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Epigral
| 93.2 | -21.7 | 64.9 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Epigral
|
1,936.3 | 8,421.0 | 2,550.1 | 356.7 | 22.7 | 21.6 | 23.5 | 4.4 |
| 1,797.7 | 9,230.9 | 1,571.8 | 186.1 | 14.0 | 13.7 | 49.6 | 6.6 | |
| 2,275.8 | 8,076.1 | 4,223.7 | 304.9 | 8.9 | 13.2 | 26.5 | 3.4 | |
| 626.6 | 6,029.5 | 3,183.5 | 624.2 | 24.0 | 18.7 | 9.7 | 1.7 | |
| 633.6 | 4,660.3 | 4,072.9 | 15.8 | -0.8 | -1.1 | -- | 0.8 | |
| 347.0 | 1,354.3 | 847.9 | 66.8 | 9.5 | 14.2 | 21.2 | 2.9 | |
| 2,780.1 | 8,921.0 | 14,273.7 | 1,350.1 | 13.8 | 11.4 | 11.5 | 1.2 | |
| 3,258.0 | 4,000.1 | 1,679.6 | 144.5 | 11.5 | 23.3 | 27.7 | 5.8 | |
| 856.2 | 1,988.3 | 382.7 | 5.7 | 1.7 | 0.8 | 348 | 2.7 | |
| 488.5 | 3,326.4 | 1,446.6 | 126.6 | 13.1 | 15 | 26.3 | 3.6 |
No Review & Analysis are available.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda,... chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India. Read more
Incorporated
2007
Chairman
Maulik Patel
Managing Director
Maulik Patel
Group
Meghmani
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Epigral Ltd stood at ₹ 3,152 Cr as on 31-Mar-25
The share price of Epigral Ltd is ₹1,936.30 (NSE) and ₹1,935.90 (BSE) as of 20-May-2025 12:39 IST. Epigral Ltd has given a return of 16.91% in the last 3 years.
Epigral Ltd has a market capitalisation of ₹ 8,421 Cr as on 20-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Epigral Ltd is 4.42 times as on 20-May-2025, a 103% premium to its peers’ median range of 2.18 times.
The P/E ratio of Epigral Ltd is 23.54 times as on 20-May-2025, a 15% discount to its peers’ median range of 27.71 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Epigral Ltd and enter the required number of quantities and click on buy to purchase the shares of Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
The prominent promoters of Epigral Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Ashishbhai Natawarlal Soparkar |
14.65%
|
|
Patel Natwarlal Meghjibhai |
9.68%
|
|
Jayantibhai Meghjibhai Patel |
8.29%
|
|
Rameshbhai Meghjibhai Patel |
6.79%
|
|
Maulik Jayantibhai Patel |
5.19%
|
The chairman of the company is Maulik Patel, and the managing director is Maulik Patel.
There is no promoter pledging in Epigral Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,049
|
|
|
8,795
|
|
|
7,970
|
|
|
5,911
|
|
|
4,790
|
|
|
3,891
|
|
|
3,085
|
|
|
1,800
|
|
|
1,428
|
| Epigral Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
21.65
|
|
Operating margin(%)
|
22.67
|
|
Net Margin(%)
|
13.9
|
|
Dividend yield(%)
|
0.31
|
Yes, TTM profit after tax of Epigral Ltd was ₹358 Cr.
₹-17.70
(
